This study investigates borderline resectable pancreatic cancer. It explores the use of a new brachytherapy device that delivers radiation in one direction to treat the cancer effectively.
The study evaluates the safety and effectiveness of this device in providing the right dose of radiation to the cancer while protecting nearby healthy tissues.
- Who can participate: Adults over 18 who can undergo anesthesia and are scheduled for certain pancreatic surgeries can participate. They must have a confirmed diagnosis of borderline resectable pancreatic cancer without metastatic disease.
- Study details: Participants will receive an investigational brachytherapy device during surgery. This device uses a special type of radiation to target cancer cells.